Loading…

Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review

The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not unco...

Full description

Saved in:
Bibliographic Details
Published in:Current neuropharmacology 2015-01, Vol.13 (1), p.101-121
Main Authors: Piacentino, Daria, Kotzalidis, Georgios D, Del Casale, Antonio, Aromatario, Maria Rosaria, Pomara, Cristoforo, Girardi, Paolo, Sani, Gabriele
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b662t-33f7a51bd56683bebc8d6aafca531b99a34c7c8794e4b29df4a17b25bb55580d3
cites
container_end_page 121
container_issue 1
container_start_page 101
container_title Current neuropharmacology
container_volume 13
creator Piacentino, Daria
Kotzalidis, Georgios D
Del Casale, Antonio
Aromatario, Maria Rosaria
Pomara, Cristoforo
Girardi, Paolo
Sani, Gabriele
description The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.
doi_str_mv 10.2174/1570159X13666141210222725
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4462035</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>26074746</sourcerecordid><originalsourceid>FETCH-LOGICAL-b662t-33f7a51bd56683bebc8d6aafca531b99a34c7c8794e4b29df4a17b25bb55580d3</originalsourceid><addsrcrecordid>eNp1UcuO1DAQjBCIXRZ-AYUPyOK3kwvSaMUC0kogdpG4WbbTmRgSO7KdGc2dD8fDwAgOnLrUXVXdqq6qVxhdEyzZa8wlwrz7iqkQAjNMMCKESMIfVZe4lbwRuEOPCy685ki8qJ6l9A0hwlsin1YXRCDJJBOX1cPGaxMmZxvt-xi24J2t7zPE4Pp6TVCXdv0pHewYFp3HMIXtoXa-3uRxggzput7U94eUYda5KD_DzsH-efVk0FOCF7_rVfXl9u3Dzfvm7uO7Dzebu8YIQXJD6SA1x6bnQrTUgLFtL7QerOYUm67TlFlpW9kxYIZ0_cA0loZwYzjnLerpVfXm5LusZobegs9RT2qJbtbxoIJ26t-Jd6Pahp1iTBBEeTHoTgY2hpQiDGctRuoYtfpv1EX78u_lZ-WfbAvhx4lgyvZRz8k68BbOxDHnRe33ewVrhO86wQQ2KxtmFRbwa5wK9rlo1TIuqnwmgtKxpDyBcin5X7ep43FqF6Z1BoXpcbAWoNKit6UiTH8Cycavsg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review</title><source>PubMed Central (Open Access)</source><creator>Piacentino, Daria ; Kotzalidis, Georgios D ; Del Casale, Antonio ; Aromatario, Maria Rosaria ; Pomara, Cristoforo ; Girardi, Paolo ; Sani, Gabriele</creator><creatorcontrib>Piacentino, Daria ; Kotzalidis, Georgios D ; Del Casale, Antonio ; Aromatario, Maria Rosaria ; Pomara, Cristoforo ; Girardi, Paolo ; Sani, Gabriele</creatorcontrib><description>The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.</description><identifier>ISSN: 1570-159X</identifier><identifier>EISSN: 1875-6190</identifier><identifier>DOI: 10.2174/1570159X13666141210222725</identifier><identifier>PMID: 26074746</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers Ltd</publisher><subject>Anabolic Agents - adverse effects ; Antisocial Personality Disorder - psychology ; Athletes - psychology ; Athletic Performance - psychology ; Humans ; Mental Disorders - chemically induced ; Mental Disorders - psychology ; Psychopathology ; Steroids - adverse effects ; Substance-Related Disorders - epidemiology ; Testosterone Congeners - adverse effects</subject><ispartof>Current neuropharmacology, 2015-01, Vol.13 (1), p.101-121</ispartof><rights>2015 Bentham Science Publishers 2015 Gabriele Sani</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b662t-33f7a51bd56683bebc8d6aafca531b99a34c7c8794e4b29df4a17b25bb55580d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462035/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462035/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26074746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piacentino, Daria</creatorcontrib><creatorcontrib>Kotzalidis, Georgios D</creatorcontrib><creatorcontrib>Del Casale, Antonio</creatorcontrib><creatorcontrib>Aromatario, Maria Rosaria</creatorcontrib><creatorcontrib>Pomara, Cristoforo</creatorcontrib><creatorcontrib>Girardi, Paolo</creatorcontrib><creatorcontrib>Sani, Gabriele</creatorcontrib><title>Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review</title><title>Current neuropharmacology</title><addtitle>CN</addtitle><description>The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.</description><subject>Anabolic Agents - adverse effects</subject><subject>Antisocial Personality Disorder - psychology</subject><subject>Athletes - psychology</subject><subject>Athletic Performance - psychology</subject><subject>Humans</subject><subject>Mental Disorders - chemically induced</subject><subject>Mental Disorders - psychology</subject><subject>Psychopathology</subject><subject>Steroids - adverse effects</subject><subject>Substance-Related Disorders - epidemiology</subject><subject>Testosterone Congeners - adverse effects</subject><issn>1570-159X</issn><issn>1875-6190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1UcuO1DAQjBCIXRZ-AYUPyOK3kwvSaMUC0kogdpG4WbbTmRgSO7KdGc2dD8fDwAgOnLrUXVXdqq6qVxhdEyzZa8wlwrz7iqkQAjNMMCKESMIfVZe4lbwRuEOPCy685ki8qJ6l9A0hwlsin1YXRCDJJBOX1cPGaxMmZxvt-xi24J2t7zPE4Pp6TVCXdv0pHewYFp3HMIXtoXa-3uRxggzput7U94eUYda5KD_DzsH-efVk0FOCF7_rVfXl9u3Dzfvm7uO7Dzebu8YIQXJD6SA1x6bnQrTUgLFtL7QerOYUm67TlFlpW9kxYIZ0_cA0loZwYzjnLerpVfXm5LusZobegs9RT2qJbtbxoIJ26t-Jd6Pahp1iTBBEeTHoTgY2hpQiDGctRuoYtfpv1EX78u_lZ-WfbAvhx4lgyvZRz8k68BbOxDHnRe33ewVrhO86wQQ2KxtmFRbwa5wK9rlo1TIuqnwmgtKxpDyBcin5X7ep43FqF6Z1BoXpcbAWoNKit6UiTH8Cycavsg</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Piacentino, Daria</creator><creator>Kotzalidis, Georgios D</creator><creator>Del Casale, Antonio</creator><creator>Aromatario, Maria Rosaria</creator><creator>Pomara, Cristoforo</creator><creator>Girardi, Paolo</creator><creator>Sani, Gabriele</creator><general>Bentham Science Publishers Ltd</general><general>Bentham Science Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review</title><author>Piacentino, Daria ; Kotzalidis, Georgios D ; Del Casale, Antonio ; Aromatario, Maria Rosaria ; Pomara, Cristoforo ; Girardi, Paolo ; Sani, Gabriele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b662t-33f7a51bd56683bebc8d6aafca531b99a34c7c8794e4b29df4a17b25bb55580d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anabolic Agents - adverse effects</topic><topic>Antisocial Personality Disorder - psychology</topic><topic>Athletes - psychology</topic><topic>Athletic Performance - psychology</topic><topic>Humans</topic><topic>Mental Disorders - chemically induced</topic><topic>Mental Disorders - psychology</topic><topic>Psychopathology</topic><topic>Steroids - adverse effects</topic><topic>Substance-Related Disorders - epidemiology</topic><topic>Testosterone Congeners - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piacentino, Daria</creatorcontrib><creatorcontrib>Kotzalidis, Georgios D</creatorcontrib><creatorcontrib>Del Casale, Antonio</creatorcontrib><creatorcontrib>Aromatario, Maria Rosaria</creatorcontrib><creatorcontrib>Pomara, Cristoforo</creatorcontrib><creatorcontrib>Girardi, Paolo</creatorcontrib><creatorcontrib>Sani, Gabriele</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piacentino, Daria</au><au>Kotzalidis, Georgios D</au><au>Del Casale, Antonio</au><au>Aromatario, Maria Rosaria</au><au>Pomara, Cristoforo</au><au>Girardi, Paolo</au><au>Sani, Gabriele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review</atitle><jtitle>Current neuropharmacology</jtitle><addtitle>CN</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>13</volume><issue>1</issue><spage>101</spage><epage>121</epage><pages>101-121</pages><issn>1570-159X</issn><eissn>1875-6190</eissn><abstract>The use of anabolic-androgenic steroids (AASs) by professional and recreational athletes is increasing worldwide. The underlying motivations are mainly performance enhancement and body image improvement. AAS abuse and dependence, which are specifically classified and coded by the DSM-5, are not uncommon. AAS-using athletes are frequently present with psychiatric symptoms and disorders, mainly somatoform and eating, but also mood, and schizophrenia-related disorders. Some psychiatric disorders are typical of athletes, like muscle dysmorphia. This raises the issue of whether AAS use causes these disorders in athletes, by determining neuroadaptive changes in the reward neural circuit or by exacerbating stress vulnerability, or rather these are athletes with premorbid abnormal personalities or a history of psychiatric disorders who are attracted to AAS use, prompted by the desire to improve their appearance and control their weights. This may predispose to eating disorders, but AASs also show mood destabilizing effects, with longterm use inducing depression and short-term hypomania; withdrawal/discontinuation may be accompanied by depression. The effects of AASs on anxiety behavior are unclear and studies are inconsistent. AASs are also linked to psychotic behavior. The psychological characteristics that could prompt athletes to use AASs have not been elucidated.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers Ltd</pub><pmid>26074746</pmid><doi>10.2174/1570159X13666141210222725</doi><tpages>21</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1570-159X
ispartof Current neuropharmacology, 2015-01, Vol.13 (1), p.101-121
issn 1570-159X
1875-6190
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4462035
source PubMed Central (Open Access)
subjects Anabolic Agents - adverse effects
Antisocial Personality Disorder - psychology
Athletes - psychology
Athletic Performance - psychology
Humans
Mental Disorders - chemically induced
Mental Disorders - psychology
Psychopathology
Steroids - adverse effects
Substance-Related Disorders - epidemiology
Testosterone Congeners - adverse effects
title Anabolic-androgenic Steroid use and Psychopathology in Athletes. A Systematic Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T11%3A59%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anabolic-androgenic%20Steroid%20use%20and%20Psychopathology%20in%20Athletes.%20A%20Systematic%20Review&rft.jtitle=Current%20neuropharmacology&rft.au=Piacentino,%20Daria&rft.date=2015-01-01&rft.volume=13&rft.issue=1&rft.spage=101&rft.epage=121&rft.pages=101-121&rft.issn=1570-159X&rft.eissn=1875-6190&rft_id=info:doi/10.2174/1570159X13666141210222725&rft_dat=%3Cpubmed_cross%3E26074746%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b662t-33f7a51bd56683bebc8d6aafca531b99a34c7c8794e4b29df4a17b25bb55580d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26074746&rfr_iscdi=true